Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)

被引:8
|
作者
Wang, Xueying [1 ]
Xue, Gang [1 ]
Pan, Zhengying [1 ]
机构
[1] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, State Key Lab Chem Oncogen,Engn Lab Chiral Drug S, Shenzhen 518055, Peoples R China
基金
中国国家自然科学基金;
关键词
ITK; Tyrosine kinase; Covalent inhibitor; T-cell receptor; Indolylindazole; IRREVERSIBLE INHIBITORS; TEC KINASES; DISCOVERY; FAMILY; SAR; RLK;
D O I
10.1016/j.ejmech.2019.111918
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Interleukin-2 inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, plays an important role in T cell signaling downstream of the T-cell receptor (TCR). Herein we report the discovery of a series of indolylindazole based covalent ITK inhibitors with nanomolar inhibitory potency against ITK, good kinase selectivity and potent inhibition of the phosphorylation of PLC gamma l and ERK1/2 in living cells. A computational study provided insight into the interactions between inhibitors and Phe437 at the ATP binding pocket of ITK, suggesting that both edge-to-face pi-pi interaction and the dihedral torsion angle contribute to inhibitors' potency. Compounds 43 and 55 stood out as selective covalent inhibitors with potent cellular activity, which could be used as chemical tools for further study of ITK functions. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Discovery and Structure-Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors
    Charrier, Jean-Damien
    Miller, Andrew
    Kay, David P.
    Brenchley, Guy
    Twin, Heather C.
    Collier, Philip N.
    Ramaya, Sharn
    Keily, Shazia B.
    Durrant, Steven J.
    Knegtel, Ronald M. A.
    Tanner, Adam J.
    Brown, Kieron
    Curnock, Adam P.
    Jimenez, Juan-Miguel
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) : 2341 - 2350
  • [2] Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)
    Trani, Giancarlo
    Barker, John J.
    Bromidge, Steven M.
    Brookfield, Frederick A.
    Burch, Jason D.
    Chen, Yuan
    Eigenbrot, Charles
    Heifetz, Alexander
    Ismaili, M. Hicham A.
    Johnson, Adam
    Krulle, Thomas M.
    MacKinnon, Colin H.
    Maghames, Rosemary
    McEwan, Paul A.
    Montalbetti, Christian A. G. N.
    Ortwine, Daniel F.
    Perez-Fuertes, Yolanda
    Vaidya, Darshan G.
    Wang, Xiaolu
    Zarrin, Ali A.
    Pei, Zhonghua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (24) : 5818 - 5823
  • [3] Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK)
    MacKinnon, Colin H.
    Lau, Kevin
    Burch, Jason D.
    Chen, Yuan
    Dines, Jonathon
    Ding, Xiao
    Eigenbrot, Charles
    Heifetz, Alexander
    Jaochico, Allan
    Johnson, Adam
    Kraemer, Joachim
    Kruger, Susanne
    Kruelle, Thomas M.
    Liimatta, Marya
    Ly, Justin
    Maghames, Rosemary
    Montalbetti, Christian A. G. N.
    Ortwine, Daniel F.
    Perez-Fuertes, Yolanda
    Shia, Steven
    Stein, Daniel B.
    Trani, Giancarlo
    Vaidya, Darshan G.
    Wang, Xiaolu
    Bromidge, Steven M.
    Wu, Lawren C.
    Pei, Zhonghua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (23) : 6331 - 6335
  • [4] Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design
    Cook, Brian N.
    Bentzien, Joerg
    White, Andre
    Nemoto, Peter A.
    Wang, Ji
    Man, Chuk C.
    Soleymanzadeh, Fariba
    Khine, Hnin Hnin
    Kashem, Mohammed A.
    Kugler, Stanley Z., Jr.
    Wolak, John P.
    Roth, Gregory P.
    De Lombaert, Stephane
    Pullen, Steven S.
    Takahashi, Hidenori
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 773 - 777
  • [5] Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors
    Pastor, Richard M.
    Burch, Jason D.
    Magnuson, Steven
    Ortwine, Daniel F.
    Chen, Yuan
    De La Torre, Kelly
    Ding, Xiao
    Eigenbrot, Charles
    Johnson, Adam
    Liimatta, Marya
    Liu, Yichin
    Shia, Steven
    Wang, Xiaolu
    Wu, Lawren C.
    Pei, Zhonghua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (11) : 2448 - 2452
  • [6] Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors
    Pastor, Richard
    Burch, Jason
    Magnuson, Steven
    Pei, Zhonghua
    Ortwine, Daniel
    Eigenbrot, Charles
    Wu, Lawren
    Liu, Yichin
    De La Torre, Kelly
    Johnson, Adam
    Chen, Yuan
    Ding, Xiao
    Liimatta, Marya
    Shia, Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [7] Enantioselective synthesis of GNE-6688, a potent and selective inhibitor of interleukin-2 inducible T-cell kinase (ITK)
    Moore, Jared
    Lau, Kevin
    Xu, Xiaofeng
    Zhang, Yamin
    Burch, Jason D.
    TETRAHEDRON LETTERS, 2019, 60 (11) : 785 - 788
  • [8] Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay
    Zapf, Christoph W.
    Gerstenberger, Brian S.
    Xing, Li
    Limburg, David C.
    Anderson, David R.
    Caspers, Nicole
    Han, Seungil
    Aulabaugh, Ann
    Kurumbail, Ravi
    Shakya, Subarna
    Li, Xin
    Spaulding, Vikki
    Czerwinski, Robert M.
    Seth, Nilufer
    Medley, Quintus G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10047 - 10063
  • [9] Lessons learned from targeting interleukin-2 inducible T cell kinase (ITK) by a covalent approach
    Zapf, Christoph W.
    Gerstenberger, Brian S.
    Xing, Li
    Limburg, David C.
    Han, Seungil
    Seth, Nilufer
    Medley, Quintus G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [10] Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders
    Reneau, John C.
    Hwang, Steven R.
    Murga-Zamalloa, Carlos A.
    Buggy, Joseph J.
    Janc, James W.
    Wilcox, Ryan A.
    BLOOD, 2018, 132